All results

5 results for tas 102 metastatic or locally advanced unresectable adenocarcinoma

• Study of XL092 in Comb. with Immuno-Oncology Agents in Subjects With Solid Tumors (STELLAR-002)

  This is a multicenter Phase 1b, open label, dose-escalation and cohort-expansion study, evaluating the safety, tolerability, PK, preliminary antitumor…

  Ages

  18 Years - N/A

  Sexes

  All

• A Study of ASP1002 in Adults for Treatment of Solid Tumors

  ASP1002 is a potential new treatment for people with certain solid tumors. Before ASP1002 is available as a treatment, the researchers need to understand how…

  Ages

  18 Years - N/A

  Sexes

  All

• Intravesical BCG vs GEMDOCE in NMIBC (BRIDGE)

  The study hypothesis is that BCG naïve non-muscle invasive bladder cancer (NMIBC) patients treated with intravesical Gemcitabine + Docetaxel (GEMDOCE) will…

  Ages

  18 Years - N/A

  Sexes

  All

• NRG-BR009: Testing the addition of chemo to SOC in breast cancer patients at high risk of recurrence

  This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to…

  Ages

  18 Years - 60 Years

  Sexes

  Female

• Addition of Pembrolizumab to Usual Intravesical Gemcitabine for Treatment of BCG-Unresponsive NMIBC

  This phase II trial studies the effect of adding pembrolizumab to gemcitabine in treating patients with non-muscle invasive bladder cancer whose cancer does…

  Ages

  18 Years - N/A

  Sexes

  All